Amgen Beats First-Quarter Expectations, But Shares Slide As Investors Watch Obesity SpaceInvestors Business Daily • 05/02/24
Insights Into Amgen (AMGN) Q1: Wall Street Projections for Key MetricsZacks Investment Research • 04/29/24
AMGEN TO SUBMIT TEPROTUMUMAB MARKETING AUTHORIZATION APPLICATION TO THE EUROPEAN MEDICINES AGENCYPRNewsWire • 04/26/24
FTC looking to accelerate inquiry into prescription-drug middlemen, chair saysMarket Watch • 04/23/24
Goldman Sachs Has 6 Dividend Blue Chips on Its Conviction List of Top Stocks24/7 Wall Street • 04/23/24
Big pharma is looking to fatten profits with buyouts of weight-loss drug companies. Here are 4 candidates.Market Watch • 04/16/24